Patent · US Active

Piperidinyl compounds that selectively bind integrins

US8110683B2 · kind B2 · utility

0Cited by

13References

24Claims

0Family size

Assignee

Janssen Pharmaceutica NA · BE

Inventors

Bart De Corte · Southampton, US
William A. Kinney · Newtown, US
Bruce E. Maryanoff · Robinson Township, US
Shyamali Ghosh · Norristown, US
Li Liu · Beijing, CN

Key dates

Filing date	Dec 22, 2010
Grant date	Feb 7, 2012
Priority date	—
Expiry date	Dec 22, 2030

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/582
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention is directed to piperidinyl compounds that selectively bind integrin receptors and methods for treating an integrin mediated disorder.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.